← Back to Search

Effect of Tai Chi as Treatment for IBS-C

N/A
Waitlist Available
Led By Kyle Staller, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to final visit. through study completion, up to 18 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if Tai Chi can help people with IBS-C feel better by reducing their symptoms through gentle exercises and deep breathing. Tai Chi has been shown to improve symptoms in various chronic conditions, including fibromyalgia and Parkinson's disease.

Eligible Conditions
  • Irritable Bowel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to final visit. through study completion, up to 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to final visit. through study completion, up to 18 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
IBS Symptom Severity Score at 12 Weeks
Secondary study objectives
Abdominal Discomfort Scale Score at 12 Weeks
Bloating Scale Score at 12 Weeks
Constipation Severity Scale Score at 12 Weeks
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tai Chi TreatmentExperimental Treatment1 Intervention
All patients in the trial will receive 1-hour Tai Chi lessons once per week for a total of 8 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tai Chi
2014
Completed Phase 2
~1660

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,023 Previous Clinical Trials
13,317,918 Total Patients Enrolled
5 Trials studying Irritable Bowel Syndrome
157 Patients Enrolled for Irritable Bowel Syndrome
Kyle Staller, MD, MPHPrincipal InvestigatorMassachusetts General Hospital
2 Previous Clinical Trials
105 Total Patients Enrolled
1 Trials studying Irritable Bowel Syndrome
52 Patients Enrolled for Irritable Bowel Syndrome
~6 spots leftby Dec 2025